We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Brammer Bio

News List

Thermo Fisher buys Brammer Bio for $1.7bn pharmatimes
March 27, 2019
Thermo Fisher, another life sciences group pitching in on the future of gene therapy, has announced plans to enter into a definitive agreement to acquire Brammer Bio for approximately $1.7 billion.
Brammer Bio, Sarepta Enter Long-term Mfg. Tie-up contractpharma
June 19, 2018
Sarepta Therapeutics, a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, has entered into a long-term strategic manufacturing partnership with Brammer B
Brammer Bio expands Cell and Gene Therapy Capacity in Florida and Massachusetts biospectrumasia
September 27, 2017
Brammer Bio expands Cell and Gene Therapy Capacity in Florida and Massachusetts Both sites will feature Pall Life Sciences enabling technologies for efficient cell and gene therapy manufacturing.